During the past decade, Bürgerspital Solothurn conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bürgerspital Solothurn" #1 sponsor was "Swiss Group for Clinical Cancer Research" with 7 trials, followed by "University Hospital Inselspital, Berne" with 3 trials sponsored, "University Hospital, Basel, Switzerland" with 3 trials sponsored, "Bürgerspital Solothurn" with 2 trials sponsored and "Mark Coburn" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bürgerspital Solothurn" #1 collaborator was "Kantonsspital Liestal" with 2 trials as a collaborator, "Spital STS AG" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bürgerspital Solothurn" with 1 trials as a collaborator and "Cantonal Hospital of St. Gallen" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Bürgerspital Solothurn" are "Lymphoma" (2 trials), "Prostate Cancer" (2 trials), "Anthracyclines" (1 trials), "Arthrosis" (1 trials) and "Avascular Necrosis of the Femoral Head" (1 trials). Many other conditions were trialed in "Bürgerspital Solothurn" in a lesser frequency.

Most popular intervention types in "Bürgerspital Solothurn" are "Drug" (8 trials), "Other" (3 trials), "Procedure" (3 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (2 trials), "paclitaxel" (2 trials), "Enzalutamide" (1 trials), "Exercise Training" (1 trials) and "Inhalational anesthetic" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bürgerspital Solothurn" are 14 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Bürgerspital Solothurn". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Bürgerspital Solothurn, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Bürgerspital Solothurn, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".